332 related articles for article (PubMed ID: 1831516)
41. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
42. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
Iwabuchi S; Takatori M; Okabe K
Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
[TBL] [Abstract][Full Text] [Related]
43. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
44. [Laboratory tests of coagulation and fibrinolysis for the diagnosis of rheumatoid arthritis].
Koshihara K; Fukutake K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():358-61. PubMed ID: 15799378
[No Abstract] [Full Text] [Related]
45. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
46. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
Iijima K
Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
[No Abstract] [Full Text] [Related]
47. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
48. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
49. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis of predictive state of disseminated intravascular coagulation].
Yamamoto K; Saito H
Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531
[TBL] [Abstract][Full Text] [Related]
51. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
52. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
53. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
54. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
55. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
56. Activation of intravascular coagulation in Bell's palsy.
Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
[No Abstract] [Full Text] [Related]
57. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
58. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
59. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
60. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
